4-Methyl-4-phenylpentan-2-one
Common Name: |
4-Methyl-4-phenylpentan-2-one |
IUPAC Name: |
4-methyl-4-phenylpentan-2-one |
Molecular Formula: |
C12H16O |
SMILES: |
CC(=O)CC(C)(C)C1=CC=CC=C1 |
Inchi: |
1S/C12H16O/c1-10(13)9-12(2,3)11-7-5-4-6-8-11/h4-8H,9H2,1-3H3 |
Inchi Key: |
PFDVPCSDZXZDMF-UHFFFAOYSA-N |
Cas No: |
7403-42-1 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
176.25 |
Mass (g/mol) |
176.12 |
Molar Refractivity |
55.53 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
3 |
Rings |
1 |
TPSA |
17.07 |
Hetero Atoms |
1 |
Heavy Atoms |
13 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
252.00 to 253.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.02 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.42 |
LogP |
2.943 |
iLOGP |
2.20 |
XLOGP3 |
2.71 |
WLOGP |
2.94 |
MLOGP |
2.97 |
ESOL Log S |
-2.78 |
ESOL Solubility (mg/ml) |
0.29 |
ESOL Solubility (mol/l) |
0.002 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.72 |
Ali Solubility (mg/ml) |
0.33 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-3.96 |
Silicos-IT Solubility (mg/ml) |
0.02 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.45 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.789 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
1 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.167 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |